Indonesia's 2026 Health Sovereignty: Homegrown Bio-TCV Set to Protect Millions, BPOM RI Guarantees Global Quality
Indonesia has launched Bio-TCV, a homegrown typhoid conjugate vaccine ready to protect millions in 2026. BPOM RI rigorously oversees the process, ensuring every dose meets global quality standards to achieve national health independence.